#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia (in remission) Nephroblastoma Oropharyngeal squamous cell carcinoma Neovascular age-related macular degeneration Krabbe's disease Hepatocellular carcinoma Oropharyngeal cancer recurrent Infertility female Hypergammaglobulinaemia benign monoclonal Essential thrombocythaemia Frontotemporal dementia Cholestatic pruritus Renal disorder Hypotransferrinaemia Epilepsy More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Diagnostics Ocular melanoma – Life with Disease Skin angiosarcoma – Basic Information Nodal marginal zone B-cell lymphoma – Life with Disease Haemophilia A without inhibitors – Life with Disease Angelman’s syndrome – Life with Disease Factor VIII deficiency – Treatment Malignant fibrous histiocytoma Angiosarcoma non-metastatic – Trials in Disease Wolfram syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    WEF-001 Vancomycin Hydrochloride FG001 ICEF15 Methoxsalen Rusfertide SARACATINIB D-Biotin Purified Egg Phospholipids Ly3541860 Lucerastat Zagociguat INSULIN DEGLUDEC Inclisiran Sodium Amivantamab Ampicillin HAFNIUM OXIDE Human Coagulation Factor Vii Daratumumab Carmustine More therapies…

    Learn about Your Condition

    Lupus nephritis Brain stem glioma Epithelioid sarcoma Dermatitis Neuroendocrine carcinoma Soft tissue sarcoma Generalised anxiety disorder Biliary adenoma Infection Renal cancer Glioma Deafness Perineal injury Ocular myasthenia Small intestine leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hodgkin’s disease

  • A Study of Pembrolizumab and Radiotherapy for Patients with Early-Stage Favorable Classic Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Germany

  • Study of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Brentuximab Vedotin
    • Dacarbazine Citrate
    • Cyclophosphamide
    Germany

  • Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Nivolumab
    Italy Poland Spain

  • Study on Preventing Hypothyroidism in Patients with Medulloblastoma and Pediatric Lymphoma Using Levothyroxine During Radiation Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Levothyroxine
    Italy

  • Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Tislelizumab
    Italy

  • Phase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Bleomycin
    • Brentuximab Vedotin
    • Vinblastine Sulfate
    Belgium Denmark Ireland The Netherlands Portugal Slovakia +1
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!